TRYVIO
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97131670
- Registration number
- 8118620
- Mark type
- Stylized text
- Filed
- 18 Nov 2021
- Published for opposition
- 13 Sept 2022
- Registered
- 27 Jan 2026
- Attorney of record
- Mary Margaret L. O'Donnell
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of inflammatory diseases, cardiovascular and pulmonary diseases, metabolic diseases, digital ulcers, and cerebrovascular diseases
Owner
- Idorsia Pharmaceuticals Ltd, Allschwil, CH
- Idorsia Pharmaceuticals Ltd, Allschwil, CH
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, NEW BRUNSWICK, NJ, US
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 05 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 08 May 2025 — USE AMENDMENT FILED
- 17 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 31 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2024 — SOU EXTENSION 4 GRANTED
- 31 Oct 2024 — SOU EXTENSION 4 FILED
- 31 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 04 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 May 2024 — SOU EXTENSION 3 GRANTED
- 11 Apr 2024 — SOU EXTENSION 3 FILED